India's Pharmaceutical Exports

Country Profile

Jamaica

Jamaica is a growing market for Indian pharmaceuticals — $28.7M in FY 2025–26, with 1.9× growth over the past decade. Medicines accounts for 95% of shipments, with vaccines contributing $407K. The compound annual growth rate since FY2015 stands at 6.3%.

🇯🇲 $28.7M · 1.9× growth since FY2015 · 6.3% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$28.7M
Exports FY2025–26 DGCIS
1.9×
Growth FY2015→2026
6.3%
CAGR FY2015→2026
95%
Medicines Share
5
Product Categories Supplied
Jamaica is a growing market for Indian pharmaceuticals — $28.7M in FY 2025–26, with 1.9× growth over the past decade. Medicines accounts for 95% of shipments, with vaccines contributing $407K. The compound annual growth rate since FY2015 stands at 6.3%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $27.3M (94.9%) Surgical & Hospital Supplies $747K (2.6%) Vaccines $407K (1.4%) Medicine Ingredients $278K (1.0%) Traditional & Herbal $26K (0.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Jamaica in the RBI overseas direct investment dataset (2011–2026).